It can be hard to know what improvement looks like with atopic dermatitis treatment. Find out what signs experts say to look ...

VIENNA — More than half of all patients with moderate-to-severe atopic dermatitis of the hands and feet treated with lebrikizumab (Ebglyss) monotherapy in a phase 3b trial achieved the primary ...

Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...

A diluted bleach bath for this form of eczema may help reduce itch and disease severity. Find out what experts recommend.

Delgocitinib poster presentations will include new data from the Phase 3 DELTA TEEN Trial as well as findings from a wide range of health economics and outcomes research and ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Please provide your email address to receive an email when new articles are posted on . Results showed high-dose upadacitinib was the most effective treatment, yet it increased any adverse event.

Getty Images Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of presentation among ...

(NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-t ...

Data Trends provide quick, visually memorable data-driven information and insights that are useful in clinical practice. AD Prevalence in US Adults and Children AD Prevalence in US Adults and Children ...